BioCentury
ARTICLE | Clinical News

Vynfinit vintafolide: Additional Phase IIb data

September 14, 2015 7:00 AM UTC

Endocyte Inc. (NASDAQ:ECYT), West Lafayette, Ind. Product: Vynfinit vintafolide ( MK-8109, EC145) Business: Cancer Molecular target: Folate receptor Description: Folate (vitamin B9) linked to alkal...